search for



Cross mark




View (493) Download (6103) CrossRef (4)
Are Electronic Cigarettes Safer Cigarettes?
Journal of the Korean Society for Research on Nicotine and Tobacco 2011; 2(2): 69-78
Published online July 15, 2011
© 2011 The Korean Society for Research on Nicotine and Tobacco.

Jung-Rae Park1, Eun Ji Kim2, Cheol Min Lee3*

1Bethesda Samsung General Hospital, 2Korean Association of Smoking and Health, 3Healthcare System Gangnam Center Seoul National University Hospital, Seoul, Korea
Electronic cigarettes developed by Hon Lik, Chinese pharmacist, intended to reduce concentrations of toxic compounds in mainstream and side stream smoke and to help smokers give up. They are battery powered devices that mimic tobacco cigarettes by vaporizing nicotine and other chemicals into an inhalable vapor. World Health Organization named this as electronic nicotine delivery system (ENDS), and recommended that ENDS products should be regulated as combination drugs and medical devices and not as tobacco products. Because of the fact that ENDS might facilitate and perpetuate nicotine addiction, claims that ENDS assist smoking cessation should be prohibited, unless the efficacy of these devices, when used as intended, is scientifically proven to the satisfaction of regulatory authorities. More rigorous chemical analyses are needed, followed by extensive research involving animal studies and, finally clinical trials in humans. Until these crucial implementation stages are completed, physicians and other healthcare professionals must inform consumers of the probable risk of the claims of manufactures of electronic cigarettes.
Keywords : Electronic cigarette; Smoking cessation; Effectiveness; Safety
  1. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health 2010; 10: 231.
    Pubmed KoreaMed CrossRef
  2. Henningfield JE, Zaatari GS. Electronic nicotine delivery systems: emerging science foundation for policy. Tob Control 2010; 19: 89-90.
    Pubmed CrossRef
  3. Flouris AD, Oikonomou DN. Electronic cigarettes: miracle or menace? BMJ 2010; 340: c311.
    Pubmed CrossRef
  4. Report on the scientific basis of tobacco product regulation: third report of a WHO study group. Geneva: World Health Organazation 2009.
  5. Administration UFaD. Evaluation of E-cigarettes. 2009.
  6. Wikipedia. Electronic cigarette. 2011 [cited 2011 March 10];
  7. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health 2010; 100: 2340-2.
    Pubmed KoreaMed CrossRef
  8. Myung SK. An update on the effectiveness and safety of electronc cigarettes. Symposium on E-cig; 2011; Korea Seoul. 2011.
  9. Pauly J, Li Q, Barry MB. Tobacco-free electronic cigarettes and cigars deliver nicotine and generate concern. Tob Control 2007; 16: 357.
    Pubmed KoreaMed CrossRef
  10. Heeyoung C. Report on E-cig from FDA. AsiaToday. [Internet]. 2011 April 26, 2011. [cited 2011 April 26];
  11. Laugesen M. Safety report on the Ruyan E-cigarette cartridge and inhaled aerosol. Christchurch: Health New Zealand Ltd. 2008.
  12. Actual condition survey on electronic cigarette. Seoul: Korean Consumer Safety Center. 2009.
  13. US Food and Drug Administration. Evaluation of e-cigarettes. 2009. [cited 2009 Oct 15];
  14. Lindsay J C. Technical review and analysis of FDA report: "Evaluation of e-cigarettes". Exponent, Inc. 2009.
  15. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. Eur J Clin Pharmacol 2000; 55: 737-41.
    Pubmed CrossRef
  16. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control 2010; 19: 87-8.
    Pubmed KoreaMed CrossRef
  17. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010; 12: 905-12.
    Pubmed CrossRef
  18. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010; 19: 1945-53.
    Pubmed KoreaMed CrossRef
  19. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010; 19: 98-103.
    Pubmed CrossRef
  20. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med 2011; 40: 472-5.
    Pubmed CrossRef
  21. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 2010; 1217: 7547-55.
    Pubmed CrossRef
  22. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. Am J Prev Med 2011; 40: 448-53.
    Pubmed CrossRef
  23. Yamin CK, Bitton A, Bates DW. E-cigarettes: a rapidly growing Internet phenomenon. Ann Intern Med 2010; 153: 607-9.
    Pubmed CrossRef
  24. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 2011; 32: 16-31.
    Pubmed CrossRef